US senators Warren and Smith say the president should go further to promote domestic drug manufacturing by supporting their legislation.
President Trump’s 6 August pharmaceutical manufacturing executive order does a poor job of preventing drug shortages compared to legislation Sens. Elizabeth Warren, D-MA, and Tina Smith, D-MN, recently introduced, the senators assert in a 2 September letter to the president.
Trump should work with them and other members of Congress to pass their legislation, which, they say, does more to...
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
The UK regulator approved 16 medicines containing a new active substance in the first half of this year, while the European Commission issued marketing authorizations for 20 NAS-containing drugs.
Joint clinical assessment reports must be descriptive rather than reach definitive conclusions, and must not interfere with national decision making processes, according to new EU guidance.
The agency’s plan for advanced manufacturing seeks more harmonization, while also seeking to codify internal practices with guidance and training.
Joint clinical assessment reports must be descriptive rather than reach definitive conclusions, and must not interfere with national decision making processes, according to new EU guidance.
Developments in India and Pakistan are designed to standardize how drug companies disclose their expenses associated with health care professionals.
The agency’s plan for advanced manufacturing seeks more harmonization, while also seeking to codify internal practices with guidance and training.
